Pages that link to "Q104026483"
Jump to navigation
Jump to search
The following pages link to Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease (Q104026483):
Displaying 50 items.
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase (Q24324172) (← links)
- Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 2. Epidemiological data (Q30802266) (← links)
- Short-term variability in the measurement of plasma homocysteine, fasting and post-methionine loading (Q32139792) (← links)
- Homocysteine: cholesterol of the 90s? (Q33746622) (← links)
- Moderate hyperhomocysteinemia and cardiovascular disease (Q33819518) (← links)
- Homocysteine, B vitamins, and coronary artery disease (Q33843655) (← links)
- Etiology and pathophysiology of stroke as a complex trait (Q34065857) (← links)
- The methylenetetrahydrofolate reductase gene is associated with increased cardiovascular risk in Japan, but not in other populations (Q34073644) (← links)
- Hyperhomocysteinemia and pregnancy--review of our present understanding and therapeutic implications (Q34080418) (← links)
- Impaired homocysteine metabolism and atherothrombotic disease (Q34249956) (← links)
- Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification (Q34323060) (← links)
- Homocysteine and arterial disease. Experimental mechanisms (Q35027762) (← links)
- Genetic evaluation for coronary artery disease (Q35179025) (← links)
- Elevated plasma homocysteine as risk factor for peripheral arterial disease--what is the evidence? (Q35219754) (← links)
- The incidence of hyperhomocysteinaemia in vascular patients (Q35553646) (← links)
- Hyperhomocysteinemia in heart transplantation: from bench to bedside (Q35556275) (← links)
- Hypercoagulability in Vascular Surgery Patients (Q36233246) (← links)
- Homocysteine metabolism, hyperhomocysteinaemia and vascular disease: an overview (Q36443604) (← links)
- Rationale, design and baseline characteristics of a large, simple, randomized trial of combined folic acid and vitamins B6 and B12 in high-risk patients: the Heart Outcomes Prevention Evaluation (HOPE)-2 trial (Q36883347) (← links)
- Homocysteine-lowering therapy: a role in stroke prevention? (Q36913508) (← links)
- Management of spontaneous dissection of the cervical carotid artery (Q37642624) (← links)
- Hyperhomocysteinemia and thrombophilia (Q37812131) (← links)
- Homocysteinemia as a risk factor for atherosclerosis: a review (Q38460537) (← links)
- Chromosomal mapping of quantitative trait loci contributing to stroke in a rat model of complex human disease (Q38563272) (← links)
- B vitamins in stroke prevention: time to reconsider (Q38620710) (← links)
- Correlation of Homocysteine with Cerebral Hemodynamic Abnormality, Endothelial Dysfunction Markers, and Cognition Impairment in Patients with Traumatic Brain Injury (Q39331469) (← links)
- Individual nutrient effects on length of gestation and pregnancy outcome (Q40419120) (← links)
- Abnormalities of hemostasis in ischemic stroke. (Q40868635) (← links)
- Homocysteine and vascular dysfunction. (Q40911244) (← links)
- Metabolite assays in cobalamin and folate deficiency (Q40931029) (← links)
- Higher export rate of homocysteine in a human endothelial cell line than in other human cell lines (Q40993242) (← links)
- Laboratory diagnosis of hemorrhagic and thrombotic disorders. (Q41024567) (← links)
- Protein binding of homocysteine and other thiols in HeLa cell cultures after addition of homocysteine and copper ions (Q41054019) (← links)
- The cell-damaging effects of low amounts of homocysteine and copper ions in human cell line cultures are caused by oxidative stress (Q41083459) (← links)
- The effects of homocysteine and copper ions on the concentration and redox status of thiols in cell line cultures (Q41103765) (← links)
- Population variation and genetics of plasma homocyst(e)ine level (Q41115550) (← links)
- Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives (Q41127825) (← links)
- Metabolism of homocysteine, its relation to the other cellular thiols and its mechanism of cell damage in a cell culture line (human histiocytic cell line U-937) (Q41281849) (← links)
- Inherited metabolic diseases affecting the carrier (Q41375620) (← links)
- Homocysteine and myocardial infarction (Q41439884) (← links)
- Clinical chemistry and molecular biology of homocysteine metabolism: an update (Q41485243) (← links)
- Disorders of homocysteine metabolism (Q41521452) (← links)
- The case for mild hyperhomocysteinaemia as a risk factor (Q41521469) (← links)
- Effects of homocysteine on acetylcholine‐ and adenosine‐induced vasodilatation of pancreatic vascular bed in rats (Q42027675) (← links)
- From birth to conception. Open or closed (Q43463957) (← links)
- Total plasma homocysteine concentrations in Puerto Rican patients with ischemic heart disease (Q43565681) (← links)
- A prospective survey of risk factors in young adults with arterial occlusive disease (Q43575859) (← links)
- A 31 bp VNTR in the cystathionine beta-synthase (CBS) gene is associated with reduced CBS activity and elevated post-load homocysteine levels (Q43723747) (← links)
- Hyperhomocyst(e)inemia and hemostatic factors: the atherosclerosis risk in communities study (Q43978616) (← links)
- Homocysteine, a risk factor for coronary artery disease or not? A meta-analysis (Q44045023) (← links)